FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology and pharmacology, and concerns the endothelial dysfunction correction. That is ensured by administering an activated-potentiated form of antibodies to C-terminal fragment of angiotensin II AT1 receptor.
EFFECT: administering the agent as a single agent therapy provides normalising the endothelial function substantially completely.
5 cl, 1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2527689C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543331C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543332C2 |
| METHOD OF TREATMENT AND PREVENTION OF ARTERIAL HYPERTENSION AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ARTERIAL HYPERTENSION | 2010 |
|
RU2525156C2 |
| METHOD OF TREATING CHRONIC CARDIAC FAILURE AND PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC CARDIAC FAILURE | 2011 |
|
RU2523451C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2541166C2 |
| METHOD OF TREATING VEGETOVASCULAR DYSTONIA AND PHARMACEUTICAL COMPOSITION FOR TREATING VEGETOVASCULAR DYSTONIA | 2010 |
|
RU2523557C2 |
| METHOD FOR INCREASE OF PHARMACOLOGICAL ACTIVITY OF ACTIVE AGENT OF DRUG PREPARATION AND PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2526153C2 |
| METHOD OF TREATING CHRONIC HEART FAILURE AND PHARMACEUTICAL COMPOSITION FOR COMPLEX THERAPY OF CHRONIC HEART FAILURE | 2010 |
|
RU2525155C2 |
| MEDICATION FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2536228C2 |
